Cargando…
Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities
As of now, therapeutic strategies for the novel coronavirus (SARS-CoV-2) are limited and much focus has been placed on social distancing techniques to “flatten the curve”. Initial treatment efforts including ventilation and hydroxychloroquine garnered significant controversy and today, SARS-CoV-2 ou...
Autor principal: | Hacking, Sean M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467009/ https://www.ncbi.nlm.nih.gov/pubmed/33254534 http://dx.doi.org/10.1016/j.mehy.2020.110227 |
Ejemplares similares
-
SARS-CoV-2 Impact on Red Blood Cell Morphology
por: Kondratov, Kirill A., et al.
Publicado: (2023) -
Infection of red blood cells by SARS-CoV-2: new evidence
por: Khawaja, Uzzam Ahmed, et al.
Publicado: (2021) -
SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
por: Coke, Christopher J., et al.
Publicado: (2021) -
Redox Status Is the Mainstay of SARS-CoV-2 and Host for Producing Therapeutic Opportunities
por: Thirupathi, Anand, et al.
Publicado: (2022) -
SARS-CoV-2: an opportunity for hospital pharmacy
por: Claramunt García, Raquel, et al.
Publicado: (2022)